KEYTRUDA® (pembrolizumab) from Merck Awarded Prix Galien USA 2015 Best Biotechnology Product Award

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. NVDA
3. META
4. SPY
5. MSFT
6. VKTX
7. DCOY
8. PRGS
9. LGND
10. ONON

Go back to KEYTRUDA® (pembrolizumab) from Merck Awarded Prix Galien USA 2015 Best Biotechnology Product Award
Merck & Co. (NYSE: MRK) Delayed: 150.91 +1.41 (0.94%)
Previous Close $149.50    52 Week High $65.46 
Open $148.69    52 Week Low $47.97 
Day High $153.57    P/E 102.66 
Day Low $148.04    EPS $1.47 
Volume 11,007,451